{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:37:45Z","timestamp":1793198265140,"version":"4.5.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Enhancer variants in Shroom3 associate with renal fibrosis (TIF), but with reduced albuminuria. Detailed mechanisms for these pleiotropic effects are unclear. Here, we focus on identifying the specific profibrotic Shroom3 motif and separating this from its anti-proteinuric function. Given the role for Rho-kinases (Rock) in TIF, and the interaction of Rock with Shroom3 ASD2-domain, we hypothesized that Shroom3-mediated Rock-activation is crucial for profibrotic function. To test this, we develop transgenic tools that overexpress wild-type- (WT-Sh3) or ASD2-domain deletion- Shroom3 (ASD2\u0394-Sh3). During TIF, Shroom3 and Rock co-expression occur in injured tubular cells and fibroblasts. In tubular- &amp; fibroblast- lines, ASD2\u0394-Sh3 overexpression reduce Rock activation, and pro-fibrotic\/pro-inflammatory transcripts downstream of TGF\u03b21\/Wnt\/Ctnnb1-signaling vs WT-Sh3. In vivo, inducible global-, or tubular-specific-, but not fibroblast-specific-, ASD2\u0394-Sh3 overexpression mitigate TIF, vs WT-Sh3 overexpression. Importantly, ASD2\u0394-Sh3 mice do not develop albuminuria, while overexpression of a distinct Fyn-binding deficient mutant Shroom3 (FBDM-Sh3) induces albuminuria. We then develop small molecule inhibitors of Shroom3-Rock interaction (P2Is) and confirm Rock inhibition with these agents in WT-Sh3 cell lines. Our lead P2I from these studies, BT1137, mitigates Rock-activation, profibrotic signaling and TIF in WT-Sh3 mice. Hence, we delineate the profibrotic Shroom3 motif and develop therapeutics for kidney disease from Shroom3 excess.<\/jats:p>","DOI":"10.1038\/s41467-025-67854-7","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T18:54:14Z","timestamp":1767120854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Design of precision therapeutics for a CKD risk allele by targeting Shroom3-Rock interaction"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5656-0205","authenticated-orcid":false,"given":"Anand","family":"Reghuvaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0086-7398","authenticated-orcid":false,"given":"Ashwani","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qisheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2045-0872","authenticated-orcid":false,"given":"Nallakandi","family":"Rajeevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Banu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeguo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Barsotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EM","family":"Tanvir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Pell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir","family":"Perincheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7940-8310","authenticated-orcid":false,"given":"Chengguo","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavya","family":"Bharathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Planoutene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Eichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Mas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0151-4200","authenticated-orcid":false,"given":"Weijia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8444-6469","authenticated-orcid":false,"given":"Lloyd G.","family":"Cantley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3071-9206","authenticated-orcid":false,"given":"Leyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaskar","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1502-2849","authenticated-orcid":false,"given":"John Cijiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9567-4299","authenticated-orcid":false,"given":"Madhav C.","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"67854_CR1","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/ng.377","volume":"41","author":"A Kottgen","year":"2009","unstructured":"Kottgen, A. et al. Multiple loci associated with indices of renal function and chronic kidney disease. Nat. Genet. 41, 712\u2013717 (2009).","journal-title":"Nat. Genet."},{"key":"67854_CR2","doi-asserted-by":"publisher","first-page":"e1002292","DOI":"10.1371\/journal.pgen.1002292","volume":"7","author":"CA Boger","year":"2011","unstructured":"Boger, C. A. et al. Association of eGFR-related loci identified by GWAS with incident CKD and ESRD. PLoS Genet. 7, e1002292 (2011).","journal-title":"PLoS Genet."},{"key":"67854_CR3","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1038\/nm.3384","volume":"19","author":"M Trudu","year":"2013","unstructured":"Trudu, M. et al. Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression. Nat. Med. 19, 1655\u20131660 (2013).","journal-title":"Nat. Med."},{"key":"67854_CR4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41392-022-01070-3","volume":"7","author":"M Zhao","year":"2022","unstructured":"Zhao, M. et al. Targeting fibrosis, mechanisms and clinical trials. Signal Transduct. Target Ther. 7, 206 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"67854_CR5","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1111\/j.1600-6143.2007.01786.x","volume":"7","author":"JC Magee","year":"2007","unstructured":"Magee, J. C. et al. Repeat organ transplantation in the United States, 1996-2005. Am. J. Transplant. 7, 1424\u20131433 (2007).","journal-title":"Am. J. Transplant."},{"key":"67854_CR6","doi-asserted-by":"publisher","first-page":"A7","DOI":"10.1053\/j.ajkd.2012.11.031","volume":"61","author":"AJ Collins","year":"2013","unstructured":"Collins, A. J. et al. US renal data system 2012 annual data report. Am. J. Kidney Dis. 61, A7\u2013e1-476 (2013).","journal-title":"Am. J. Kidney Dis."},{"key":"67854_CR7","doi-asserted-by":"crossref","unstructured":"Deshmukh HA, Palmer CN, Morris AD, Colhoun HM. Investigation of known estimated glomerular filtration rate loci in patients with Type 2 diabetes. Diabetic medicine: a journal of the British Diabetic Association, 2558-2570 (2013).","DOI":"10.1111\/dme.12211"},{"key":"67854_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1172\/JCI76902","volume":"125","author":"MC Menon","year":"2015","unstructured":"Menon, M. C. et al. Intronic locus determines SHROOM3 expression and potentiates renal allograft fibrosis. J. Clin. Invest 125, 208\u2013221 (2015).","journal-title":"J. Clin. Invest"},{"key":"67854_CR9","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1681\/ASN.2017080856","volume":"29","author":"JW Prokop","year":"2018","unstructured":"Prokop, J. W. et al. Characterization of Coding\/Noncoding Variants for SHROOM3 in Patients with CKD. J. Am. Soc. Nephrol. 29, 1525\u20131535 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"67854_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/FPC.0000000000000251","volume":"27","author":"L Yan","year":"2017","unstructured":"Yan, L. et al. The influence of living donor SHROOM3 and ABCB1 genetic variants on renal function after kidney transplantation. Pharmacogenet Genomics 27, 19\u201326 (2017).","journal-title":"Pharmacogenet Genomics"},{"key":"67854_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1101\/gr.182881.114","volume":"25","author":"NC Yeo","year":"2015","unstructured":"Yeo, N. C. et al. Shroom3 contributes to the maintenance of the glomerular filtration barrier integrity. Genome Res. 25, 57\u201365 (2015).","journal-title":"Genome Res."},{"key":"67854_CR12","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1681\/ASN.2015060621","volume":"27","author":"H Khalili","year":"2016","unstructured":"Khalili, H. et al. Developmental origins for kidney disease due to shroom3 deficiency. J. Am. Soc. Nephrol. 27, 2965\u20132973 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"67854_CR13","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1093\/hmg\/dds138","volume":"21","author":"JW Ellis","year":"2012","unstructured":"Ellis, J. W. et al. Validated SNPs for eGFR and their associations with albuminuria. Hum. Mol. Genet. 21, 3293\u20133298 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"67854_CR14","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1681\/ASN.2018060573","volume":"29","author":"C Wei","year":"2018","unstructured":"Wei, C. et al. SHROOM3-FYN Interaction Regulates Nephrin Phosphorylation and Affects Albuminuria in Allografts. J. Am. Soc. Nephrol. 29, 2641\u20132657 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"67854_CR15","doi-asserted-by":"publisher","first-page":"e150004","DOI":"10.1172\/jci.insight.150004","volume":"6","author":"K Banu","year":"2021","unstructured":"Banu, K. et al. AMPK mediates regulation of glomerular volume and podocyte survival. JCI Insight 6, e150004 (2021).","journal-title":"JCI Insight"},{"key":"67854_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2121-7-18","volume":"7","author":"O Hagens","year":"2006","unstructured":"Hagens, O. et al. A new standard nomenclature for proteins related to Apx and Shroom. BMC cell Biol. 7, 18 (2006).","journal-title":"BMC cell Biol."},{"key":"67854_CR17","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0092-8674(00)81537-8","volume":"99","author":"JD Hildebrand","year":"1999","unstructured":"Hildebrand, J. D. & Soriano, P. Shroom, a PDZ domain-containing actin-binding protein, is required for neural tube morphogenesis in mice. Cell 99, 485\u2013497 (1999).","journal-title":"Cell"},{"key":"67854_CR18","doi-asserted-by":"publisher","first-page":"20542","DOI":"10.1074\/jbc.M512463200","volume":"281","author":"ML Dietz","year":"2006","unstructured":"Dietz, M. L., Bernaciak, T. M., Vendetti, F., Kielec, J. M. & Hildebrand, J. D. Differential actin-dependent localization modulates the evolutionarily conserved activity of Shroom family proteins.  J. Biol. Chem. 281, 20542\u201320554 (2006).","journal-title":"J. Biol. Chem."},{"key":"67854_CR19","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.1182\/blood-2009-11-251132","volume":"115","author":"V Audard","year":"2010","unstructured":"Audard, V. et al. Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes. Blood 115, 3756\u20133762 (2010).","journal-title":"Blood"},{"key":"67854_CR20","doi-asserted-by":"publisher","first-page":"8010","DOI":"10.3892\/mmr.2015.4467","volume":"12","author":"I Baba","year":"2015","unstructured":"Baba, I., Egi, Y., Utsumi, H., Kakimoto, T. & Suzuki, K. Inhibitory effects of fasudil on renal interstitial fibrosis induced by unilateral ureteral obstruction. Mol. Med. Rep. 12, 8010\u20138020 (2015).","journal-title":"Mol. Med. Rep."},{"key":"67854_CR21","first-page":"4126913","volume":"2020","author":"F Xie","year":"2020","unstructured":"Xie, F. et al. Attenuation of diabetic nephropathy in diabetic mice by fasudil through regulation of macrophage polarization. J. Diab. Res 2020, 4126913 (2020).","journal-title":"J. Diab. Res"},{"key":"67854_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1080\/0886022X.2017.1349677","volume":"39","author":"Z Gao","year":"2017","unstructured":"Gao, Z., Zhu, W., Zhang, H., Li, Z. & Cui, T. The influence of fasudil on renal proximal tubular cell epithelial-mesenchymal transition induced by parathormone. Ren. Fail 39, 575\u2013581 (2017).","journal-title":"Ren. Fail"},{"key":"67854_CR23","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1038\/s41588-024-01904-6","volume":"56","author":"GB Loeb","year":"2024","unstructured":"Loeb, G. B. et al. Variants in tubule epithelial regulatory elements mediate most heritable differences in human kidney function. Nat. Genet. 56, 2078\u20132092 (2024).","journal-title":"Nat. Genet."},{"key":"67854_CR24","doi-asserted-by":"publisher","first-page":"15874","DOI":"10.1073\/pnas.2005477117","volume":"117","author":"Y Kirita","year":"2020","unstructured":"Kirita, Y., Wu, H., Uchimura, K., Wilson, P. C. & Humphreys, B. D. Cell profiling of mouse acute kidney injury reveals conserved cellular responses to injury. Proc. Natl. Acad. Sci. USA 117, 15874\u201315883 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67854_CR25","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.cmet.2022.09.026","volume":"34","author":"H Li","year":"2022","unstructured":"Li, H., Dixon, E. E., Wu, H. & Humphreys, B. D. Comprehensive single-cell transcriptional profiling defines shared and unique epithelial injury responses during kidney fibrosis. Cell Metab. 34, 1977\u20131998.e1979 (2022).","journal-title":"Cell Metab."},{"key":"67854_CR26","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1038\/s41588-025-02285-0","volume":"57","author":"KA Klotzer","year":"2025","unstructured":"Klotzer, K. A. et al. Analysis of individual patient pathway coordination in a cross-species single-cell kidney atlas. Nat. Genet. 57, 1922\u20131934 (2025).","journal-title":"Nat. Genet."},{"key":"67854_CR27","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1681\/ASN.2021121548","volume":"33","author":"NS Shin","year":"2022","unstructured":"Shin, N. S. et al. Arginase-1 is required for macrophage-mediated renal tubule regeneration. J. Am. Soc. Nephrol. 33, 1077\u20131086 (2022).","journal-title":"J. Am. Soc. Nephrol."},{"key":"67854_CR28","doi-asserted-by":"publisher","first-page":"4571","DOI":"10.1242\/dev.083253","volume":"139","author":"S Ernst","year":"2012","unstructured":"Ernst, S. et al. Shroom3 is required downstream of FGF signalling to mediate proneuromast assembly in zebrafish. Development 139, 4571\u20134581 (2012).","journal-title":"Development"},{"key":"67854_CR29","doi-asserted-by":"publisher","DOI":"10.1177\/20543581231212038","volume":"10","author":"A Paul","year":"2023","unstructured":"Paul, A. et al. The Good and the Bad of SHROOM3 in Kidney Development and Disease: A Narrative Review. Can. J. Kidney Health Dis. 10, 20543581231212038 (2023).","journal-title":"Can. J. Kidney Health Dis."},{"key":"67854_CR30","doi-asserted-by":"publisher","DOI":"10.1177\/20543581231165716","volume":"10","author":"A Lawlor","year":"2023","unstructured":"Lawlor, A. et al. Minimal Kidney Disease Phenotype in Shroom3 Heterozygous Null Mice. Can. J. Kidney Health Dis. 10, 20543581231165716 (2023).","journal-title":"Can. J. Kidney Health Dis."},{"key":"67854_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32634-0","volume":"13","author":"L Xu","year":"2022","unstructured":"Xu, L., Guo, J., Moledina, D. G. & Cantley, L. G. Immune-mediated tubule atrophy promotes acute kidney injury to chronic kidney disease transition. Nat. Commun. 13, 4892 (2022).","journal-title":"Nat. Commun."},{"key":"67854_CR32","doi-asserted-by":"publisher","first-page":"316ra193","DOI":"10.1126\/scitranslmed.aac7071","volume":"7","author":"W Ju","year":"2015","unstructured":"Ju, W. et al. Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker. Sci. Transl. Med. 7, 316ra193 (2015).","journal-title":"Sci. Transl. Med"},{"key":"67854_CR33","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1681\/ASN.2015050504","volume":"27","author":"MG Sampson","year":"2016","unstructured":"Sampson, M. G. et al. Using population genetics to interrogate the monogenic nephrotic syndrome diagnosis in a case cohort. J. Am. Soc. Nephrol. 27, 1970\u20131983 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"67854_CR34","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.kint.2022.10.023","volume":"103","author":"LH Mariani","year":"2023","unstructured":"Mariani, L. H. et al. Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis. Kidney Int. 103, 565\u2013579 (2023).","journal-title":"Kidney Int."},{"key":"67854_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40086-3","volume":"14","author":"M Chen","year":"2023","unstructured":"Chen, M. et al. HCK induces macrophage activation to promote renal inflammation and fibrosis via suppression of autophagy. Nat. Commun. 14, 4297 (2023).","journal-title":"Nat. Commun."},{"key":"67854_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12868-015-0171-5","volume":"16","author":"HM Dickson","year":"2015","unstructured":"Dickson, H. M., Wilbur, A., Reinke, A. A., Young, M. A. & Vojtek, A. B. Targeted inhibition of the Shroom3-Rho kinase protein-protein interaction circumvents Nogo66 to promote axon outgrowth. BMC Neurosci. 16, 34 (2015).","journal-title":"BMC Neurosci."},{"key":"67854_CR37","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1006\/excr.2000.5046","volume":"261","author":"M Amano","year":"2000","unstructured":"Amano, M., Fukata, Y. & Kaibuchi, K. Regulation and functions of Rho-associated kinase. Exp. Cell Res. 261, 44\u201351 (2000).","journal-title":"Exp. Cell Res."},{"key":"67854_CR38","doi-asserted-by":"publisher","first-page":"4612","DOI":"10.1128\/MCB.02061-05","volume":"26","author":"DR Croft","year":"2006","unstructured":"Croft, D. R. & Olson, M. F. The Rho GTPase effector ROCK regulates cyclin A, cyclin D1, and p27Kip1 levels by distinct mechanisms. Mol. Cell Biol. 26, 4612\u20134627 (2006).","journal-title":"Mol. Cell Biol."},{"key":"67854_CR39","doi-asserted-by":"publisher","first-page":"15548","DOI":"10.1073\/pnas.2536483100","volume":"100","author":"NA Bhowmick","year":"2003","unstructured":"Bhowmick, N. A. et al. TGF-beta-induced RhoA and p160ROCK activation is involved in the inhibition of Cdc25A with resultant cell-cycle arrest. Proc. Natl. Acad. Sci. USA 100, 15548\u201315553 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67854_CR40","doi-asserted-by":"publisher","first-page":"e12994","DOI":"10.7554\/eLife.12203","volume":"5","author":"S Kumper","year":"2016","unstructured":"Kumper, S. et al. Rho-associated kinase (ROCK) function is essential for cell cycle progression, senescence and tumorigenesis. Elife 5, e12994 (2016).","journal-title":"Elife"},{"key":"67854_CR41","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/bj3510095","volume":"351","author":"SP Davies","year":"2000","unstructured":"Davies, S. P., Reddy, H., Caivano, M. & Cohen, P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J. 351, 95\u2013105 (2000).","journal-title":"Biochem J."},{"key":"67854_CR42","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1021\/acs.jmedchem.5b00683","volume":"59","author":"Y Feng","year":"2016","unstructured":"Feng, Y., LoGrasso, P. V., Defert, O. & Li, R. Rho kinase (ROCK) inhibitors and their therapeutic potential. J. Med. Chem. 59, 2269\u20132300 (2016).","journal-title":"J. Med. Chem."},{"key":"67854_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09936-x","volume":"10","author":"RC Calizo","year":"2019","unstructured":"Calizo, R. C. et al. Disruption of podocyte cytoskeletal biomechanics by dasatinib leads to nephrotoxicity. Nat. Commun. 10, 2061 (2019).","journal-title":"Nat. Commun."},{"key":"67854_CR44","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/ng.568","volume":"42","author":"A Kottgen","year":"2010","unstructured":"Kottgen, A. et al. New loci associated with kidney function and chronic kidney disease. Nat. Genet. 42, 376\u2013384 (2010).","journal-title":"Nat. Genet."},{"key":"67854_CR45","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ekir.2025.02.018","volume":"10","author":"D Ghasemi-Semeskandeh","year":"2025","unstructured":"Ghasemi-Semeskandeh, D. et al. Clinical and metabolic signatures of FAM47E-SHROOM3 haplotypes in a general population sample. Kidney Int. Rep. 10, 1495\u20131508 (2025).","journal-title":"Kidney Int. Rep."},{"key":"67854_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77952-9","volume":"10","author":"R Matsuura","year":"2020","unstructured":"Matsuura, R. et al. SHROOM3, the gene associated with chronic kidney disease, affects the podocyte structure. Sci. Rep. 10, 21103 (2020).","journal-title":"Sci. Rep."},{"key":"67854_CR47","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1681\/ASN.2016111166","volume":"28","author":"JCQ Velez","year":"2017","unstructured":"Velez, J. C. Q. et al. Deficiency of the angiotensinase aminopeptidase a increases susceptibility to glomerular injury. J. Am. Soc. Nephrol. 28, 2119\u20132132 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"67854_CR48","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1242\/bio.20147450","volume":"3","author":"D Das","year":"2014","unstructured":"Das, D. et al. The interaction between Shroom3 and Rho-kinase is required for neural tube morphogenesis in mice. Biol. Open 3, 850\u2013860 (2014).","journal-title":"Biol. Open"},{"key":"67854_CR49","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1242\/dev.019646","volume":"135","author":"T Nishimura","year":"2008","unstructured":"Nishimura, T. & Takeichi, M. Shroom3-mediated recruitment of Rho kinases to the apical cell junctions regulates epithelial and neuroepithelial planar remodeling. Development 135, 1493\u20131502 (2008).","journal-title":"Development"},{"key":"67854_CR50","doi-asserted-by":"publisher","first-page":"306","DOI":"10.2152\/jmi.61.306","volume":"61","author":"RD Yanuaryska","year":"2014","unstructured":"Yanuaryska, R. D. et al. Sp6 regulation of Rock1 promoter activity in dental epithelial cells. J. Med. Invest. 61, 306\u2013317 (2014).","journal-title":"J. Med. Invest."},{"key":"67854_CR51","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3892\/ol.2022.13279","volume":"23","author":"AA Farooqi","year":"2022","unstructured":"Farooqi, A. A. et al. Regulation of ROCK1\/2 by long non-coding RNAs and circular RNAs in different cancer types. Oncol. Lett. 23, 159 (2022).","journal-title":"Oncol. Lett."},{"key":"67854_CR52","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3892\/br.2014.323","volume":"2","author":"H Ji","year":"2014","unstructured":"Ji, H. et al. Rho\/Rock cross-talks with the transforming growth factor-beta\/Smad pathway participates in lung fibroblast-myofibroblast differentiation. Biomed. Rep. 2, 787\u2013792 (2014).","journal-title":"Biomed. Rep."},{"key":"67854_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93580-3","volume":"11","author":"N Igarashi","year":"2021","unstructured":"Igarashi, N., Honjo, M. & Aihara, M. mTOR inhibitors potentially reduce TGF-beta2-induced fibrogenic changes in trabecular meshwork cells. Sci. Rep. 11, 14111 (2021).","journal-title":"Sci. Rep."},{"key":"67854_CR54","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ydbio.2020.05.013","volume":"464","author":"MD Durbin","year":"2020","unstructured":"Durbin, M. D., O\u2019Kane, J., Lorentz, S., Firulli, A. B. & Ware, S. M. SHROOM3 is downstream of the planar cell polarity pathway and loss-of-function results in congenital heart defects. Dev. Biol. 464, 124\u2013136 (2020).","journal-title":"Dev. Biol."},{"key":"67854_CR55","doi-asserted-by":"publisher","first-page":"148","DOI":"10.31083\/j.fbl2807148","volume":"28","author":"X Zhao","year":"2023","unstructured":"Zhao, X. et al. Alterations of the m(6)A methylation induced by TGF-beta2 in ARPE-19 cells. Front Biosci. 28, 148 (2023).","journal-title":"Front Biosci."},{"key":"67854_CR56","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1046\/j.1523-1755.2002.00328.x","volume":"61","author":"K Nagatoya","year":"2002","unstructured":"Nagatoya, K. et al. Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction. Kidney Int. 61, 1684\u20131695 (2002).","journal-title":"Kidney Int."},{"key":"67854_CR57","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s42003-022-03300-4","volume":"5","author":"K Matoba","year":"2022","unstructured":"Matoba, K. et al. ROCK2-induced metabolic rewiring in diabetic podocytopathy. Commun. Biol. 5, 341 (2022).","journal-title":"Commun. Biol."},{"key":"67854_CR58","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1159\/000332040","volume":"34","author":"L Zhou","year":"2011","unstructured":"Zhou, L. et al. Amelioration of albuminuria in ROCK1 knockout mice with streptozotocin-induced diabetic kidney disease. Am. J. Nephrol. 34, 468\u2013475 (2011).","journal-title":"Am. J. Nephrol."},{"key":"67854_CR59","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nm.1857","volume":"14","author":"C Faul","year":"2008","unstructured":"Faul, C. et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat. Med. 14, 931\u2013938 (2008).","journal-title":"Nat. Med."},{"key":"67854_CR60","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/ncb1400","volume":"8","author":"K Asanuma","year":"2006","unstructured":"Asanuma, K. et al. Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling. Nat. cell Biol. 8, 485\u2013491 (2006).","journal-title":"Nat. cell Biol."},{"key":"67854_CR61","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000488984","volume":"4","author":"Y Feng","year":"2018","unstructured":"Feng, Y., Liang, Y., Ren, J. & Dai, C. Canonical Wnt signaling promotes macrophage proliferation during kidney fibrosis. Kidney Dis. 4, 95\u2013103 (2018).","journal-title":"Kidney Dis."},{"key":"67854_CR62","doi-asserted-by":"publisher","first-page":"e14688","DOI":"10.14814\/phy2.14688","volume":"9","author":"C Zhang","year":"2021","unstructured":"Zhang, C. et al. Genetic susceptibility of hypertension-induced kidney disease. Physiol. Rep. 9, e14688 (2021).","journal-title":"Physiol. Rep."},{"key":"67854_CR63","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.kint.2024.04.019","volume":"106","author":"ED Siew","year":"2024","unstructured":"Siew, E. D. et al. Genome-wide association study of hospitalized patients and acute kidney injury. Kidney Int. 106, 291\u2013301 (2024).","journal-title":"Kidney Int."},{"key":"67854_CR64","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1681\/ASN.2007070794","volume":"19","author":"J Prakash","year":"2008","unstructured":"Prakash, J. et al. Inhibition of renal rho kinase attenuates ischemia\/reperfusion-induced injury. J. Am. Soc. Nephrol. 19, 2086\u20132097 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"67854_CR65","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1042\/CS20200030","volume":"134","author":"R You","year":"2020","unstructured":"You, R. et al. Inhibition of ROCK2 alleviates renal fibrosis and the metabolic disorders in the proximal tubular epithelial cells. Clin. Sci. 134, 1357\u20131376 (2020).","journal-title":"Clin. Sci."},{"key":"67854_CR66","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.1172\/JCI125519","volume":"129","author":"M Chang-Panesso","year":"2019","unstructured":"Chang-Panesso, M. et al. FOXM1 drives proximal tubule proliferation during repair from acute ischemic kidney injury. J. Clin. Invest. 129, 5501\u20135517 (2019).","journal-title":"J. Clin. Invest."},{"key":"67854_CR67","doi-asserted-by":"publisher","first-page":"e26419","DOI":"10.1371\/journal.pone.0026419","volume":"6","author":"D Kentrup","year":"2011","unstructured":"Kentrup, D. et al. Hydroxyfasudil-mediated inhibition of ROCK1 and ROCK2 improves kidney function in rat renal acute ischemia-reperfusion injury. PLoS ONE 6, e26419 (2011).","journal-title":"PLoS ONE"},{"key":"67854_CR68","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1681\/ASN.2019010068","volume":"30","author":"L Xu","year":"2019","unstructured":"Xu, L., Sharkey, D. & Cantley, L. G. Tubular GM-CSF promotes late MCP-1\/CCR2-mediated fibrosis and inflammation after ischemia\/reperfusion injury. J. Am. Soc. Nephrol. 30, 1825\u20131840 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"67854_CR69","doi-asserted-by":"publisher","first-page":"688060","DOI":"10.3389\/fmed.2021.688060","volume":"8","author":"E Cantero-Navarro","year":"2021","unstructured":"Cantero-Navarro, E. et al. Role of macrophages and related cytokines in kidney disease. Front. Med. 8, 688060 (2021).","journal-title":"Front. Med."},{"key":"67854_CR70","doi-asserted-by":"publisher","first-page":"F610","DOI":"10.1152\/ajprenal.00076.2024","volume":"327","author":"I Melchinger","year":"2024","unstructured":"Melchinger, I. et al. VCAM-1 mediates proximal tubule-immune cell cross talk in failed tubule recovery during AKI-to-CKD transition. Am. J. Physiol. Ren. Physiol. 327, F610\u2013F622 (2024).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"67854_CR71","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1681\/ASN.2015060647","volume":"27","author":"K Takaori","year":"2016","unstructured":"Takaori, K. et al. Severity and frequency of proximal tubule injury determines renal prognosis. J. Am. Soc. Nephrol. 27, 2393\u20132406 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"67854_CR72","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fphar.2015.00276","volume":"6","author":"S Hartmann","year":"2015","unstructured":"Hartmann, S., Ridley, A. J. & Lutz, S. The function of rho-associated kinases ROCK1 and ROCK2 in the pathogenesis of cardiovascular disease. Front Pharm. 6, 276 (2015).","journal-title":"Front Pharm."},{"key":"67854_CR73","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.toxlet.2013.11.031","volume":"225","author":"JM Basgen","year":"2014","unstructured":"Basgen, J. M. & Sobin, C. Early chronic low-level lead exposure produces glomerular hypertrophy in young C57BL\/6J mice. Toxicol. Lett. 225, 48\u201356 (2014).","journal-title":"Toxicol. Lett."},{"key":"67854_CR74","doi-asserted-by":"publisher","first-page":"e27669","DOI":"10.7554\/eLife.27669","volume":"6","author":"C Hepler","year":"2017","unstructured":"Hepler, C. et al. Directing visceral white adipocyte precursors to a thermogenic adipocyte fate improves insulin sensitivity in obese mice. Elife 6, e27669 (2017).","journal-title":"Elife"},{"key":"67854_CR75","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1681\/ASN.2013050563","volume":"25","author":"A Scarpellini","year":"2014","unstructured":"Scarpellini, A. et al. Syndecan-4 knockout leads to reduced extracellular transglutaminase-2 and protects against tubulointerstitial fibrosis. J. Am. Soc. Nephrol. 25, 1013\u20131027 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"67854_CR76","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1211\/0022357023051","volume":"56","author":"N Sato","year":"2004","unstructured":"Sato, N. et al. Acute nephrotoxicity of aristolochic acids in mice. J. Pharm. Pharm. 56, 221\u2013229 (2004).","journal-title":"J. Pharm. Pharm."},{"key":"67854_CR77","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/biom9040141","volume":"9","author":"E Martinez-Klimova","year":"2019","unstructured":"Martinez-Klimova, E., Aparicio-Trejo, O. E., Tapia, E. & Pedraza-Chaverri, J. Unilateral ureteral obstruction as a model to investigate fibrosis-attenuating treatments. Biomolecules 9, 141 (2019).","journal-title":"Biomolecules"},{"key":"67854_CR78","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.12688\/f1000research.15931.1","volume":"7","author":"SW Wingett","year":"2018","unstructured":"Wingett, S. W. & Andrews, S. FastQ screen: a tool for multi-genome mapping and quality control. F1000Res 7, 1338 (2018).","journal-title":"F1000Res"},{"key":"67854_CR79","unstructured":"Andrews S. FastQC). https:\/\/qubeshub.org\/resources\/fastqc (2015)."},{"key":"67854_CR80","doi-asserted-by":"publisher","first-page":"e0185056","DOI":"10.1371\/journal.pone.0185056","volume":"12","author":"B Bushnell","year":"2017","unstructured":"Bushnell, B., Rood, J. & Singer, E. BBMerge - accurate paired shotgun read merging via overlap. PLoS ONE 12, e0185056 (2017).","journal-title":"PLoS ONE"},{"key":"67854_CR81","unstructured":"Bushnell B. BBMap: A Fast, Accurate, Splice-Aware Aligner In: BBMap. https:\/\/sourceforge.net\/projects\/bbmap\/. SourceForge (2024)."},{"key":"67854_CR82","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"67854_CR83","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general-purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"67854_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"67854_CR85","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1681\/ASN.2014090916","volume":"27","author":"M Schwartzman","year":"2016","unstructured":"Schwartzman, M. et al. Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure. J. Am. Soc. Nephrol. 27, 216\u2013226 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"67854_CR86","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.2337\/db07-0019","volume":"56","author":"M Toyoda","year":"2007","unstructured":"Toyoda, M., Najafian, B., Kim, Y., Caramori, M. L. & Mauer, M. Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Diabetes 56, 2155\u20132160 (2007).","journal-title":"Diabetes"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67854-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67854-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67854-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T02:02:42Z","timestamp":1769652162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67854-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67854"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67854-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,30]]},"assertion":[{"value":"13 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.G.C. declares roles as advisor to Pfizer for AKI and CKD and to Dropshot for AKI. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1086"}}